Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Shutters Huntsville Center, 175 Laid Off

NEW YORK, April 26-Invitrogen said yesterday that it would close its Huntsville, Ala. manufacturing center.


That center produced custom synthetic DNA, peptides, and antibodies; cDNA libraries; and microsatellite markers.


Invitrogen took over the Huntsville center when it acquired Research Genetics in February 2000.


Huntsville bioinformatics, genomic services and technical services operations will be moved to Carlsbad, Calif. The company will move its oligonucleotide production to Frederick, Md.


The Huntsville center currently employs more than 200 people. Invitrogen said that roughly 175 would be laid off, and the company would offer to relocate some staff to other facilities.


Closing down the center will reduce Invitrogen's annual operating costs by $8 million to $10 million, the company said.


The company expects the decision will result in a one-time $14 to $19 million charge in the second quarter, and an earnings per share charge of 16 to 21 cents.


On May 3, the company plans to open a 320,000 square foot manufacturing and distribution center in Carlsbad.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.